Validation and Advanced Development of Technologies for the Study of Biological Properties of Single Cells (R33)

Post Date

December 18th 2013

Application Due Date

April 4th 2014

Funding Opportunity Number

RFA-RM-13-020

CFDA Number(s)

93.310

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Funding

• Estimated Total Funding:

  $2500000

• Award Range:

  $None - $250000

Grant Description

This Funding Opportunity Announcement (FOA) invites applications that propose to accelerate the development of promising technologies for single cell analysis by taking them through the downstream optimization and validation process and establishing them as robust, well-characterized tools ready to transform our understanding of the biological properties of individual cells and the role those properties have in modulating the states of surrounding cells, tissues, and organs. This FOA solicits projects where proof-of-principle of the proposed technology or methodology has been established and supportive preliminary data are available. A current R21 award is not necessary. Projects should reflect the potential of single cell analysis to have a major impact on our understanding of biomedical processes, fulfill a critical unmet need by offering compelling advantages to end-users, and demonstrate the technology can be applied to multiple types of cells. It is expected that applications will have well-defined goal(s) with intermediate quantitative milestones. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued will be considered non-responsive and will not be reviewed.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-020.html